nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—SLC22A11—Conjugated Estrogens—osteoporosis	0.276	0.296	CbGbCtD
Aspartame—SLC22A11—Estradiol—osteoporosis	0.242	0.26	CbGbCtD
Aspartame—SLC22A8—Conjugated Estrogens—osteoporosis	0.16	0.172	CbGbCtD
Aspartame—SLC22A8—Estradiol—osteoporosis	0.141	0.151	CbGbCtD
Aspartame—SLC22A6—Conjugated Estrogens—osteoporosis	0.112	0.12	CbGbCtD
Aspartame—TRPV1—sciatic nerve—osteoporosis	0.0589	1	CbGeAlD
Aspartame—Spirapril—ACE—osteoporosis	0.00167	0.168	CrCbGaD
Aspartame—Quinapril—ACE—osteoporosis	0.00149	0.15	CrCbGaD
Aspartame—Lisinopril—ACE—osteoporosis	0.00149	0.15	CrCbGaD
Aspartame—Trandolapril—ACE—osteoporosis	0.00144	0.145	CrCbGaD
Aspartame—Ramipril—ACE—osteoporosis	0.00144	0.145	CrCbGaD
Aspartame—Lacosamide—CA2—osteoporosis	0.0013	0.131	CrCbGaD
Aspartame—Enalapril—ACE—osteoporosis	0.00109	0.11	CrCbGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—RAP1A—osteoporosis	1.29e-05	0.131	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—PTH1R—osteoporosis	6.59e-06	0.0669	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CALCR—osteoporosis	6.59e-06	0.0669	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—PTH—osteoporosis	3.46e-06	0.0351	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CALCR—osteoporosis	3.38e-06	0.0343	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTH1R—osteoporosis	3.38e-06	0.0343	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CNR2—osteoporosis	3.37e-06	0.0342	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—WNT1—osteoporosis	3.17e-06	0.0322	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—PTHLH—osteoporosis	2.87e-06	0.0291	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MGLL—osteoporosis	2.69e-06	0.0273	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CALCA—osteoporosis	2.53e-06	0.0256	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SOST—osteoporosis	2.21e-06	0.0224	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALCR—osteoporosis	2e-06	0.0203	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTH1R—osteoporosis	2e-06	0.0203	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.81e-06	0.0184	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTH—osteoporosis	1.78e-06	0.018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CNR2—osteoporosis	1.73e-06	0.0176	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—WNT1—osteoporosis	1.63e-06	0.0165	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MGLL—osteoporosis	1.59e-06	0.0161	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LRP5—osteoporosis	1.55e-06	0.0157	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LRP6—osteoporosis	1.48e-06	0.015	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTHLH—osteoporosis	1.47e-06	0.0149	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—POMC—osteoporosis	1.32e-06	0.0134	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CALCA—osteoporosis	1.3e-06	0.0132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TLN1—osteoporosis	1.25e-06	0.0127	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—P4HB—osteoporosis	1.08e-06	0.0109	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTH—osteoporosis	1.05e-06	0.0107	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAP1A—osteoporosis	1.03e-06	0.0105	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CNR2—osteoporosis	1.02e-06	0.0104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NFATC1—osteoporosis	1.01e-06	0.0102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DKK1—osteoporosis	9.99e-07	0.0101	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—WNT1—osteoporosis	9.62e-07	0.00976	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGA—osteoporosis	9.36e-07	0.00949	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADCY5—osteoporosis	9.22e-07	0.00936	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTHLH—osteoporosis	8.7e-07	0.00883	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BMP2—osteoporosis	8.7e-07	0.00883	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGB—osteoporosis	8.51e-07	0.00864	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.48e-07	0.0086	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PSMA2—osteoporosis	8.22e-07	0.00834	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PSMA5—osteoporosis	8.22e-07	0.00834	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALCA—osteoporosis	7.66e-07	0.00777	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KL—osteoporosis	6.95e-07	0.00706	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.79e-07	0.00689	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—POMC—osteoporosis	6.78e-07	0.00688	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6R—osteoporosis	6.62e-07	0.00671	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.47e-07	0.00656	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADCY5—osteoporosis	5.45e-07	0.00553	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.4e-07	0.00547	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPP1—osteoporosis	5.27e-07	0.00535	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IRS2—osteoporosis	4.77e-07	0.00484	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEP—osteoporosis	4.66e-07	0.00473	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ESR1—osteoporosis	4.45e-07	0.00452	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IRS1—osteoporosis	4.16e-07	0.00422	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—POMC—osteoporosis	4.01e-07	0.00407	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6R—osteoporosis	3.91e-07	0.00397	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1—osteoporosis	3.85e-07	0.00391	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.18e-07	0.00323	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—osteoporosis	2.95e-07	0.00299	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.43e-07	0.00246	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MYC—osteoporosis	2.32e-07	0.00235	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFB1—osteoporosis	2.31e-07	0.00234	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.02e-07	0.00205	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—osteoporosis	1.74e-07	0.00177	CbGpPWpGaD
